… to ProQR’s novel RNA editing platform technology called Axiomer LEIDEN, the Netherlands, May 09, 2017 (GLOBE … led to a novel proprietary RNA editing platform, called Axiomer, which in our view is the next step in RNA …
Divestment of sepofarsen and ultevursen completed – Théa to continue development of sepofarsen and ultevursen for patients with LCA10 and Usher syndrome